...
首页> 外文期刊>Mitochondrion >Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds
【24h】

Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds

机译:天然化合物优先杀死具有线粒体功能障碍的癌细胞

获取原文
获取原文并翻译 | 示例

摘要

Mitochondria play essential roles in cellular metabolism redox homeostasis and regulation of cell death Emerging evidences suggest that cancer cells exhibit various degrees of mitochondrial dysfunctions and metabolic alterations which may serve as a basis to develop therapeutic strategies to preferentially kill the malignant cells Mitochondria as a therapeutic target for cancer treatment is gaining much attention in the recent years and agents that impact mitochondria with anticancer activity have been identified and tested in vitro and in vivo using various experimental systems Anticancer agents that directly target mitochondria or indirectly affect mitochondrial functions are collectively classified as mitocans This review article focuses on several natural compounds that preferentially kill cancer cells with mitochondrial dysfunction and discusses the possible underlying mechanisms and their therapeutic implications in cancer treatment Mitocans that have been comprehensively reviewed recently are not included in this article Important issues such as therapeutic selectivity and the relevant biochemical basis are discussed in the context of future perspectives
机译:线粒体在细胞代谢氧化还原稳态和细胞死亡的调节中起重要作用。新兴证据表明,癌细胞表现出不同程度的线粒体功能障碍和代谢改变,这可以作为制定优先杀死恶性细胞的治疗策略的基础。近年来,用于癌症治疗的药物引起了广泛关注,并且已经使用各种实验系统在体内和体外鉴定和测试了具有抗癌活性的影响线粒体的药物,并直接针对线粒体或间接影响线粒体功能的抗癌药被归类为线粒体。综述文章重点介绍了优先杀死具有线粒体功能异常的癌细胞的几种天然化合物,并讨论了已被全面综述的可能的潜在机制及其在癌症治疗中的治疗意义。 d近期未包含在本文中,在将来的背景下讨论了重要问题,例如治疗选择性和相关的生化基础

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号